Abstract
Most patients with type 1 diabetes (T1D) administer insulin by multiple daily injections (MDI). However, continuous subcutaneous insulin infusion (CSII) therapy has been shown to improve glycemic control compared with MDI. The objective was to determine the key medical event and cost offsets generated over a 4-year period by introducing CSII to T1D patients who have inadequately controlled glucose metabolism on MDI in Germany. A decision-analytic budget impact model, simulating a treatment switch scenario, was developed. In the base case, all T1D patients received MDI, while in the switch scenario, 20% of the eligible T1D population, randomly selected, moved to CSII. The model focused on 2 medical endpoints and their corresponding cost offsets: severe hypoglycemic events requiring hospitalization (SHEH) and complication-borne diabetic events (CDEs) avoided. Event rates and costs were taken from the literature and official sources, adopting a health insurance perspective. Compared with the base case, treating 20% of patients with CSII in the switch scenario resulted in 47 864 fewer SHEH and 5543 fewer CDEs. This led to total cost offsets of €183 085 281 within the 4-year time horizon. Of these, 92% were driven by avoided SHEH. C...Continue Reading
References
May 1, 1983·Diabetologia·T LauritzenC Binder
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Apr 1, 1996·Diabetes Care·B W BodeP C Davidson
Aug 11, 2000·BMJ : British Medical Journal·I M StrattonR R Holman
Jun 26, 2001·Kidney International·N ChaturvediJ H Fuller
Mar 23, 2002·BMJ : British Medical Journal·John PickupSally Kerry
Mar 29, 2002·Diabetes/metabolism Research and Reviews·Bruce W BodePaul C Davidson
Mar 29, 2003·Diabetes Care·Graham P LeeseUNKNOWN DARTS/MEMO Collaboration
Aug 25, 2004·Current Medical Research and Opinion·Andrew J PalmerGiatgen A Spinas
Feb 19, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·R R McAlpineJ M M Evans
Mar 24, 2005·Journal of Pediatric Psychology·Jodi L KampsR Enrique Varela
Dec 29, 2006·PharmacoEconomics·Rachael L Fleurence, Christopher S Hollenbeak
Feb 24, 2007·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·L von FerberH Hauner
Jun 22, 2007·Patient Education and Counseling·Diane WildLinda Gonder-Frederick
Jan 19, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·A NicolucciE Vitacolonna
Mar 21, 2008·Diabetologia·K JeitlerA Siebenhofer
Jul 23, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·J C Pickup, A J Sutton
Nov 27, 2008·Diabetes·Philip E Cryer
Sep 22, 2009·Diabetes Care·Denis RaccahMarc Nicolino
Dec 17, 2009·Journal of Medical Economics·Mette HammerBrian M Frier
Jul 1, 2010·The New England Journal of Medicine·Richard M BergenstalUNKNOWN STAR 3 Study Group
Jul 17, 2010·BMC Pediatrics·Katharine BarnardNorman Waugh
Oct 6, 2010·Journal of Diabetes Science and Technology·John WalshTimothy Bailey
Jun 25, 2013·Diabetologia·A J HayesP M Clarke
Oct 9, 2013·Diabetes Care·Stefanie HäggUNKNOWN FinnDiane Study Group
Dec 9, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·S RozeJ Jendle
Jan 7, 2015·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Group for the DCCT/EDIC Research GroupJohn M Lachin
Apr 10, 2015·Cardiovascular Diabetology·Kamel MohammediGilberto Velho
Jun 24, 2015·BMJ : British Medical Journal·Isabelle SteineckUNKNOWN Swedish National Diabetes Register